english.prescrire.org > Spotlight > 100 most recent

Spotlight

Every month, the subjects in Prescrire’s Spotlight.

100 most recent :  1 | 10 | 20 | 30 | 40 | 50 | 60 | 70 | 80 | 90

Covid-19: Follow Prescrire's independent, evidence-based analysis of the pandemic

Revolving door between the public and private sectors: conflict of interest

Relugolix + estradiol + norethisterone (Ryeqo°) in uterine fibroids: not acceptable

Setmelanotide (Imcivree°) in certain, very rare, genetic forms of obesity: possibly helpful

Trimebutine: too many cardiac risks

Impending changes to European pharmaceutical regulations: part II

Dapivirine vaginal ring in the prevention of HIV

Europe and medicines

Opioids: endocrine disruptors

Impending changes to European pharmaceutical regulations: part 1

1 | 10 | 20 | 30 | 40 | 50 | 60 | 70 | 80 | 90